FIELD: chemistry.
SUBSTANCE: invention relates to a pyrazole compound having following formula (1) wherein R1 represents C1-C6 alkyl, C1-C6 alkyl substituted with a group R17, C1-C6 haloalkyl, phenyl, phenyl substituted with a number of substituents R11, or similar, R2 represents hydrogen, C1-C6 alkyl, phenyl, or phenyl optionally substituted with R e substituents R21, or similar, R3 represents a hydrogen atom or similar, X represents a single bond or -(CR6R7)n-, each of R4 and R5 independently represents C1-C6 alkyl or similar, R6 and R7 represent hydrogen atoms or C1-C6 alkyl, R8 represents phenyl, phenyl optionally substituted by k substituents R81, or similar, tautomer of such a compound or a pharmaceutically acceptable salt thereof. Invention also relates to a therapeutic agent for treatment of multiple myeloma, containing a pyrazole compound represented by formula (1) as an active ingredient.
EFFECT: said compound inhibits growth of multiple myeloma cells.
9 cl, 22 tbl, 18 ex synthesis, 4 ex of pharm. compositions, 1 ex for bioassay.
Title | Year | Author | Number |
---|---|---|---|
4-AMINO-6-(HETEROCYCLIC)PICOLINATES AND 6-AMINO-2-(HETEROCYCLIC)PYRIMIDINE-4-CARBOXYLATES AND THEIR USE AS HERBICIDES | 2014 |
|
RU2672587C2 |
OXIME-SUBSTITUTED AMIDE COMPOUND AND PEST CONTROL AGENT | 2013 |
|
RU2668547C2 |
SUBSTITUTED PYRIMIDINYLFORMYLOXIME DERIVATIVE, ITS PRODUCTION METHOD, ITS HERBICIDAL COMPOSITION, AND USE | 2018 |
|
RU2777594C2 |
BENZAMIDE COMPOUNDS | 2019 |
|
RU2801647C2 |
5-5 CONDENSED RINGS AS C5a INHIBITORS | 2018 |
|
RU2780322C2 |
BICYCLIC INHIBITORS | 2014 |
|
RU2672582C2 |
SULPHONAMIDE COMPOUND OR SALT THEREOF | 2017 |
|
RU2732572C2 |
ANALOGS OF Δ12,13-ISOTAXOL, INTERMEDIATE COMPOUNDS, METHOD OF SYNTHESIS OF INTERMEDIATE COMPOUNDS AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2142950C1 |
NEUROACTIVE STEROIDS AND METHODS OF THEIR USE | 2014 |
|
RU2808166C2 |
NEUROACTIVE STEROIDS AND METHODS FOR USE THEREOF | 2014 |
|
RU2684103C2 |
Authors
Dates
2016-05-10—Published
2011-12-01—Filed